Emerging data suggest Retatru tide , a dual stimulator targeting both GLP-1 and GIP , could represent a promising development for weight treatment. Initial patient investigations have demonstrated impressive losses in abdominal fat , conceivably outperforming other weight lose peptide body composition medications . However , more study is required